Why the study?
Do circulating biomarkers of fibrosis and angiogenesis correlate with disease severity in patients with symptomatic heart failure compared to controls?
Do circulating biomarkers of fibrosis and angiogenesis correlate with disease severity in patients with symptomatic heart failure compared to controls?
A multimarker profile demonstrates that severe heart failure is associated with enhanced collagen breakdown and reduced angiogenesis, highlighting potential pathways for targeted therapy.
No takes yet. Share an insight, caveat, or question.
Fibrosis-angiogenesis biomarker shifts may track severe HF; leaves open validation for prognosis or therapy targeting.
Morine et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: